4//SEC Filing
Jenkins Annalisa 4
Accession 0001516551-24-000038
CIK 0001516551other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:01 PM ET
Size
5.7 KB
Accession
0001516551-24-000038
Insider Transaction Report
Form 4
Jenkins Annalisa
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-29+40,000→ 40,000 totalExercise: $14.56Exp: 2034-03-01→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the one year period beginning February 29, 2024.
Documents
Issuer
Skye Bioscience, Inc.
CIK 0001516551
Entity typeother
Related Parties
1- filerCIK 0001639481
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:01 PM ET
- Size
- 5.7 KB